BioVersys AG Ratios and Metrics

Market cap in millions CHF. Fiscal year is January - December.

Millions CHF. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023
Period Ending	May '26 May 12, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Market Capitalization	157	143	-	-
Enterprise Value	97	69	-	-
Last Close Price	26.90	24.40	-	-
PS Ratio	49.55	44.94	-	-
PB Ratio	2.63	2.39	-	-
P/TBV Ratio	2.63	2.39	-	-
EV/Sales Ratio	30.40	21.69	-	-
Debt / Equity Ratio	0.36	0.36	1.59	1.86
Net Debt / Equity Ratio	-1.02	-1.02	-1.46	-1.45
Net Debt / EBITDA Ratio	3.06	3.06	0.84	0.71
Net Debt / FCF Ratio	2.74	2.74	1.00	1.06
Asset Turnover	0.05	0.05	0.04	-
Quick Ratio	9.55	9.55	3.51	3.25
Current Ratio	10.10	10.10	3.56	3.59
Return on Equity (ROE)	-61.93%	-61.93%	-194.40%	-
Return on Assets (ROA)	-19.87%	-19.87%	-33.86%	-
Return on Capital Employed (ROCE)	-24.40%	-24.40%	-74.00%	-71.40%
Earnings Yield	-13.88%	-15.30%	-	-
FCF Yield	-14.09%	-15.53%	-	-
Buyback Yield / Dilution	-68.49%	-68.49%	-11.60%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.